TRVI
Trevi Therapeutics, Inc.
Set alert
13.56 USD -0.25 -1.81%
13.44 Day range 13.91
9.99 52-week range 19.50
- YTD
- +8.31%
- 1 year
- +21.40%
- Open
- 13.78
- Prev close
- 13.81
- Mkt cap
- 1.93B
- Vol
- 1.73M
- Avg vol
- 1.95M
- EPS
- -0.35
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.44
- High
- 13.91
- Forward P/E
- -23.50
- Beta
- 0.98
- Short ratio
- 5.94
- Inst. own
- 109.87%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 14.79
- 200-d avg
- 14.33
- 1y target
- 28.18
1Y chart
Closing price and volume
Compare TRVI
Chart and line up TRVI against other symbols or a saved comparison set.
- TRVI Trevi Therapeutics, Inc.
13.56
-0.25 -1.81%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | TRVI | SPY | QQQ |
|---|---|---|---|
| Last price | 13.56 | 755.72 | 690.49 |
| Change | -0.25 | -13.64 | -24.85 |
| Change % | -1.81% | -1.77% | -3.47% |
| Open | 13.78 | 761.38 | 697.13 |
| Day high | 13.91 | 761.46 | 698.63 |
| Day low | 13.44 | 750.36 | 683.45 |
| Previous close | 13.81 | 769.36 | 715.34 |
| Volume | 1.73M | 77.70M | 85.24M |
| Average volume | 1.95M | 41.22M | 34.57M |
| Market cap | 1.93B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -0.35 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 19.50 | 779.09 | 759.66 |
| 52-week low | 9.99 | 631.97 | 558.28 |
| 1-week return | +7.53% | -0.559233% | -1.97% |
| 1-month return | -5.31% | -0.906075% | -6.66% |
| 3-month return | -26.30% | +1.89% | +1.02% |
| 6-month return | -1.45% | +5.16% | +3.41% |
| Year-to-date return | +8.31% | +10.82% | +12.40% |
| 1-year return | +21.40% | +11.16% | +10.29% |
| 2-year return | +361.22% | +32.90% | +42.71% |
| 50-day moving average | 14.79 | 767.63 | 725.41 |
| 200-day moving average | 14.33 | 728.53 | 679.17 |
| Target price | 28.18 | — | — |
| Beta | 0.984 | 0.00 | 0.00 |
| Short ratio | 5.94 | — | — |
| Institutional ownership | 109.87% | — | — |